The icare4u program offers support tools to help navigate the health challenges many people affected by these conditions face
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the launch of icare4u, program to support the mental and physical health of Indians affected by disorders caused by excessive inflammation.
Dr Jitendra Dixit, Janssen India’s Head of Medical Affairs said that conditions such as rheumatoid arthritis, psoriasis, psoriatic arthritis, axial spondyloarthropathy and inflammatory bowel disease had a “huge toll” on the mental and physical health of those affected.
Research shows that people living with inflammatory disorders are at increased risk of depression and anxiety, with those most affected also experiencing worse disease activity.
Understanding the challenges faced by patients and caregivers, the icare4u program offers support tools to help navigate the health challenges many people affected by these conditions face. It features a website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers.
The information and support tools provided are specific to rheumatoid arthritis, axial spondyloarthropathy, psoriatic arthritis, psoriasis, ulcerative colitis and Chron’s disease.
- Advertisement -